EUVIMED · CrossrefZeitschrift
Leukemia & Lymphoma
ISSN 1042-8194 · Informa UK Limited
Neueste Artikel
CD4-/CD8- double-negative aggressive mature T-cell lymphoma complicated by pure red cell aplasia: diagnostic challenges and successful allogeneic HSCT
Prognostic value of t(11;14) and second revised International Staging System in transplant ineligible newly diagnosed myeloma treated with daratumumab, lenalidomide, and dexamethasone: a Japanese multicenter retrospective study
Ibrutinib dose modification and effectiveness in Japanese patients with chronic lymphocytic leukemia: a post-hoc analysis of the Orbit study
Role of ERK signaling in pristimerin-induced apoptosis and autophagy: involvement of ROS-dependent mechanisms in Cutaneous T-cell lymphoma
Can We use delayed consolidation in chronic lymphocytic leukemia?
Clinical characteristics and prognostic factors of rheumatoid arthritis-associated lymphoproliferative disorders in the era of biologic and targeted synthetic disease-modifying antirheumatic drugs: a multicenter retrospective study
Acute myeloid leukemia with TP53 mutation: molecular mechanisms and therapeutic advances
Correction
Efficacy of continuous zanubrutinib monotherapy versus fixed-duration acalabrutinib plus venetoclax or venetoclax plus obinutuzumab in treatment-naïve chronic lymphocytic leukemia: a network meta-analysis
Low dose pre-transplant splenic radiotherapy for myeloproliferative neoplasms
Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma in Europe
Outcomes of haploidentical stem cell transplantation in pediatric Philadelphia chromosome-like B-cell acute lymphoblastic leukemia in the era of immunotherapy
Dasatinib, prednisolone, and vincristine as a ‘chemo-lite’ induction approach for Philadelphia chromosome-positive acute lymphoblastic leukemia
BCR::ABL1 emergence during menin inhibitor therapy in two patients with relapsed or refractory acute myeloid leukemia
MicroRNA dysregulation in mesenchymal stromal cells in myelodysplastic syndromes and its modulation by azacitidine and bortezomib
Patient empowerment in Hodgkin Lymphoma (HL) through continuously accessible information resources
Projected population size by treatment line in diffuse large B-cell lymphoma in the United States, 2024–2028
Perniosis-like lesions as an extramedullary manifestation preceding a chronic myelomonocytic leukemia diagnosis: a clinicopathological and molecular description
Post-transplant maintenance in acute myeloid leukemia in Italy: results of the GITMO-maintenance survey
Outpatient venetoclax initiation following obinutuzumab debulking in patients with high or medium tumor burden at baseline
Primary CNS lymphoma mimicking brain metastases with successful glucarpidase rescue and methotrexate rechallenge
First-line pemigatinib in a myeloid/lymphoid neoplasm with FGFR1 rearrangement: shifting the current treatment paradigm
The APLC 2025 consensus recommendations on the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia
Chronic myelomonocytic leukemia associated with lymphoid neoplasms
Acute promyelocytic leukemia with clonal hematopoiesis: a case study of APL in complete molecular remission transitioning to MDS/MPN and its clinical implications
Single-Cell RNA sequencing analysis of cellular heterogeneity and microenvironment-driven signaling networks in acute myeloid leukemia
Lower baseline eosinophil counts are associated with inferior survival in Mantle cell lymphoma
Time burden and treatment patterns of patients with newly diagnosed acute myeloid leukemia receiving parenteral hypomethylating agents in combination with venetoclax
Gemcitabine and oxaliplatin with or without rituximab in relapsed or refractory post-transplant lymphoproliferative disorder following renal transplantation: a single centre experience
Patients’ preferences for accepting risks and uncertainty in AML treatments within European public health care systems: a cross-sectional study in Finland, Italy, and Germany
Jahrgänge
2026 · 3472025 · 3872024 · 2932023 · 3112022 · 4762021 · 4942020 · 5192019 · 5452018 · 4362017 · 4592016 · 4952015 · 6202014 · 5402013 · 5302012 · 4662011 · 4372010 · 3702009 · 4142008 · 4202007 · 4472006 · 4592005 · 2722004 · 3972003 · 3962002 · 3882001 · 3372000 · 2971999 · 2991998 · 3031997 · 2771996 · 3201995 · 3121994 · 3001993 · 3361992 · 2561991 · 1941990 · 1271989 · 12
EUVIMED